Estimating the posterior probability that genome-wide association findings are true or false

Por Bukszár, József, McClay, Joseph L., van den Oord, Edwin J. C. G.
Publicado em 2009

The Influence of Five Monoamine Genes on Trajectories of Depressive Symptoms across Adolescence and Young Adulthood

Por Adkins, Daniel E., Daw, Jonathan K., McClay, Joseph L., van den Oord, Edwin J.C.G.
Publicado em 2012

A systematic method for estimating individual responses to treatment with antipsychotics in CATIE

Por van den Oord, Edwin J.C.G., Adkins, Daniel E., McClay, Joseph, Lieberman, Jeffrey, Sullivan, Patrick F.
Publicado em 2008

Genome-Wide and Gene-Based Association Studies of Anxiety Disorders in European and African American Samples

Por Otowa, Takeshi, Maher, Brion S., Aggen, Steven H., McClay, Joseph L., van den Oord, Edwin J., Hettema, John M.
Publicado no PLoS One (2014)

In Silico Whole Genome Association Scan for Murine Prepulse Inhibition

Por Webb, Bradley Todd, McClay, Joseph L., Vargas-Irwin, Cristina, York, Timothy P., van den Oord, Edwin J. C. G.
Publicado em 2009

Estimation of CpG coverage in whole methylome next-generation sequencing studies

Por van den Oord, Edwin JCG, Bukszar, Jozsef, Rudolf, Gábor, Nerella, Srilaxmi, McClay, Joseph L, Xie, Lin Y, Aberg, Karolina A
Publicado em 2013

A Genomewide Association Study of Citalopram Response in Major Depressive Disorder—A psychometric approach

Por Adkins, Daniel E., Åberg, Karolina, McClay, Joseph L., Hettema, John M., Kornstein, Susan G., Bukszár, József, van den Oord, Edwin J.C.G.
Publicado em 2010

SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: Data from the CATIE Study

Por Adkins, Daniel E., Khachane, Amit N., McClay, Joseph L., Åberg, Karolina, Bukszár, Jozsef, Sullivan, Patrick F., van den Oord, Edwin J.C.G.
Publicado em 2011

Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions

Por Aberg, Karolina A, Xie, Lin Y, McClay, Joseph L, Nerella, Srilaxmi, Vunck, Sarah, Snider, Sarah, Beardsley, Patrick M, van den Oord, Edwin JCG
Publicado em 2013

Neurochemical metabolomics reveals disruption to sphingolipid metabolism following chronic haloperidol administration

Por McClay, Joseph L., Vunck, Sarah A., Batman, Angela M., Crowley, James J., Vann, Robert E., Beardsley, Patrick M., van den Oord, Edwin J.
Publicado no J Neuroimmune Pharmacol (2015)

Genotype-Based Ancestral Background Consistently Predicts Efficacy and Side Effects across Treatments in CATIE and STAR*D

Por Adkins, Daniel E., Souza, Renan P., Åberg, Karolina, Clark, Shaunna L., McClay, Joseph L., Sullivan, Patrick F., van den Oord, Edwin J. C. G.
Publicado em 2013

Genome-wide association study of patient and clinician rated global impression severity during antipsychotic treatment

Por Clark, Shaunna L., Souza, Renan P, Adkins, Daniel E., Åberg, Karolina, Bukszár, József, McClay, Joseph L., Sullivan, Patrick F., van den Oord, Edwin J.C.G.
Publicado em 2013

Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure

Por McClay, Joseph L., Adkins, Daniel E., Vunck, Sarah A., Batman, Angela M., Vann, Robert E., Clark, Shaunna L., Beardsley, Patrick M., van den Oord, Edwin J. C. G.
Publicado em 2012

Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics

Por McClay, Joseph L., Adkins, Daniel E., Åberg, Karolina, Stroup, Scott, Perkins, Diana O., Vladimirov, Vladimir I., Lieberman, Jeffrey A., Sullivan, Patrick F., van den Oord, Edwin J.C.G.
Publicado em 2009

MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders

Por Kim, Albert H., Reimers, Mark, Maher, Brion, Williamson, Vernell, McMichael, Omari, McClay, Joseph L., van den Oord, Edwin J.C.G., Riley, Brien P., Kendler, Kenneth S., Vladimirov, Vladimir I.
Publicado no Schizophr Res (2010)

Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b

Por Enga, Rachel M., Rice, Ann C., Weller, Pamela, Subler, Mark A., Lee, Daiyoon, Hall, Chelsea P., Windle, Jolene J., Beardsley, Patrick M., van den Oord, Edwin J., McClay, Joseph L.
Publicado no Neurosci Lett (2017)

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish Study of High Density Schizophrenia Families (ISHDSF)

Por Thiselton, Dawn L, Vladimirov, Vladimir I, Kuo, Po-Hsiu, McClay, Joseph, Wormley, Brandon, Fanous, Ayman, O’Neill, Francis A, Walsh, Dermot, Van den Oord, Edwin JCG, Kendler, Kenneth S, Riley, Brien P
Publicado em 2007

Genome-wide association study of antipsychotic induced QTc interval prolongation

Por Åberg, Karolina, Adkins, Daniel E., Liu, Youfang, McClay, Joseph L., Bukszár, József, Jia, Peilin, Zhao, Zhongming, Perkins, Diana, Stroup, T. Scott, Lieberman, Jeffrey A., Sullivan, Patrick F., van den Oord, Edwin J.C.G.
Publicado em 2010

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

Por Adkins, Daniel E., Åberg, Karolina, McClay, Joseph L., Bukszár, József, Zhao, Zhongming, Jia, Peilin, Stroup, T. Scott, Perkins, Diana, McEvoy, Joseph P., Lieberman, Jeffrey A., Sullivan, Patrick F., van den Oord, Edwin J.C.G.
Publicado em 2010

Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization

Por Adkins, Daniel E., McClay, Joseph L., Vunck, Sarah A., Batman, Angela M., Vann, Robert E., Clark, Shaunna L., Souza, Renan P., Crowley, James J., Sullivan, Patrick F., van den Oord, Edwin J.C.G., Beardsley, Patrick M.
Publicado em 2013